<DOC>
	<DOCNO>NCT00397683</DOCNO>
	<brief_summary>The purpose study test MK0822 disease activity patient osteoarthritis knee . Disease modify activity MK0822 assess measurement knee cartilage use Magnetic Resonance Imaging ( MRI ) knee . This early phase trial specific protocol information proprietary publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>A 52-Week Study Assess Effects MK0822 Knee Osteoarthritis ( MK-0822-011 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Patients symptomatic knee osteoarthritis least 6 month base clinical radiographic criterion Patients general good health must certain level knee pain take pain medicine day Specific radiographic ( Xray ) MRI feature must also satisfy Nonosteoarthritic cause knee pain Ineligibility undergo MRI knee due patient tolerability safety reason Previous septic arthritis , tibial osteotomy knee replacement knee Acute injury knee ligament meniscus past 2 year Knee arthroscopy past 12 month Anticipated arthroscopy surgery next 18 month Use intraarticular injection hyaluronan ( e.g . Hyalgan ( TM ) , Synvisc ( TM ) , Orthovisc ( TM ) ) past 6 month , injection glucocorticoid ( e.g . Kenalog ( TM ) , Aristospan ( TM ) , DepoMedrol ( TM ) ) past 3 month anticipate knee injection study Glucosamine chondroitin sulfate allowable stable dose past 3 month continue dose study Other exclusion criterion applyPlease ask study doctor detail</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>